Daniel Marsh

Daniel Marsh

Senior Markets Analyst

Daniel Marsh is a senior markets analyst at StockTi with over 12 years of experience covering U.S. and global equity markets. He holds a CFA charter and previously worked as an equity research associate at a major Wall Street firm. Daniel specializes in macroeconomic analysis, market trends, and cross-sector investment themes. His work focuses on translating complex market data into actionable insights for individual and institutional investors.

Markets, Economy, Analysis 4,308 articles

Articles by Daniel Marsh

Keel Infrastructure Jumps 5% Pre-Market on Russell Index Inclusion and Convertible Note Dynamics
Markets

Keel Infrastructure Jumps 5% Pre-Market on Russell Index Inclusion and Convertible Note Dynamics

Keel Infrastructure Corp. (NASDAQ: KEEL) gained 5% pre-market to $6.60, driven by Russell 3000 index inclusion and a $458 million convertible note deal. The conversion price sits 12% above current levels.

Diplomacy and AI Demand Drive Market Shifts
Markets

Diplomacy and AI Demand Drive Market Shifts

Progress in US-Iran talks lowers oil prices, while AI demand lifts SK Hynix past Samsung. Markets await Micron earnings and PCE inflation data.

SPY QQQ USO
Fiji tourism boom raises questions about local economic benefits
Economy

Fiji tourism boom raises questions about local economic benefits

Fiji Airways cabin crew earn FJ$3,000–FJ$4,500 monthly, 2.6 times minimum wage, while tourism arrivals hit 85,405 in May. InterContinental Fiji backs a surf program for local children, highlighting uneven benefits.

SPY
Everyman Cinema Plans London Stock Exchange Delisting Amid Turnaround Strategy
Markets

Everyman Cinema Plans London Stock Exchange Delisting Amid Turnaround Strategy

Everyman Media Group plans to exit the London Stock Exchange's AIM following a board recommendation, aiming for a private takeover led by Blue Coast Capital to drive a strategic turnaround.

EWU
Cognizant Plunges 10% Amid Accenture Guidance Cut, Nasdaq-100 Removal
Markets

Cognizant Plunges 10% Amid Accenture Guidance Cut, Nasdaq-100 Removal

Cognizant shares tumbled 10.49% to $43.70 after Accenture's weaker growth forecast, a Berenberg downgrade, and its looming exit from the Nasdaq-100, wiping out $2.4 billion in equity value.

CTSH ACN
T1 Energy Closes Above Key $9 Level as Financing Deadline Looms
Markets

T1 Energy Closes Above Key $9 Level as Financing Deadline Looms

T1 Energy (NYSE: TE) closed at $9.35, up 3.43%, driven by Bernstein's Market Perform initiation, an Intertek CEA 'A' grade, and shareholder approval to double shares. The market now eyes the $225 million G2_Austin financing need.

TE
Campbell's Set for S&P 500 Exit as Small-Cap Shift Looms
Markets

Campbell's Set for S&P 500 Exit as Small-Cap Shift Looms

Campbell's (CPB) drops 7.3% before its index rebalance from S&P 500 to S&P SmallCap 600. The stock yields 7.4%, but guidance signals a 23-26% EPS drop.

CPB
Infosys Stock Faces Pressure After Accenture Downgrade Triggers IT Selloff
Markets

Infosys Stock Faces Pressure After Accenture Downgrade Triggers IT Selloff

Infosys shares plunged 6.75% as Accenture's reduced fiscal 2026 growth forecast triggered a sector-wide selloff, pushing Nifty IT to a three-year low. Investors are reassessing Indian IT stocks ahead of Infosys' July 23 earnings.

INFY ACN
Fiserv Insiders Invest $1.72M Amid CEO Shakeup, Stock Lags
Markets

Fiserv Insiders Invest $1.72M Amid CEO Shakeup, Stock Lags

Six Fiserv insiders purchased 34,781 shares worth $1.72 million following CEO Mike Lyons' sudden departure, but FISV closed at $47.86, below their average cost.

FISV
CoreWeave to Join Nasdaq-100 After 17% Weekly Surge
Markets

CoreWeave to Join Nasdaq-100 After 17% Weekly Surge

CoreWeave joins the Nasdaq-100 on Monday after a 17% weekly gain, triggering index fund buying from over $800 billion in assets. The AI cloud firm's Q1 revenue doubled to $2.08 billion, but net loss widened to $740 million.

CRWV
FDA Decisions Loom for ACHV and UNCY Amid Manufacturing Hurdles
Markets

FDA Decisions Loom for ACHV and UNCY Amid Manufacturing Hurdles

ACHV dropped 9.5% as its FDA deadline passed with a manufacturing-related rejection expected; UNCY fell 2.8% ahead of a June 29 decision. Both stocks face third-party manufacturing issues.

ACHV UNCY
Ondas Stock Edges Up Slightly After $125M Cyberhawk Deal
Markets

Ondas Stock Edges Up Slightly After $125M Cyberhawk Deal

ONDS ended the short week nearly flat after announcing a $125M deal to acquire Cyberhawk, aiming to expand recurring software-and-services revenue in critical infrastructure intelligence.

ONDS